Eaton Vance Management’s NeoGenomics NEO Stock Holding History

Eaton Vance Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.54M	Sell	410,828 -258	-0.1%	-$2.56K	0.01%	874
2022 Q2	$3.35M	Sell	411,086 -26,056	-6%	-$249K	﹤0.01%	921
2022 Q1	$5.31M	Buy	437,142 +24,182	+6%	+$509K	0.01%	870
2021 Q4	$14.1M	Sell	412,960 -613	-0.1%	-$24K	0.02%	548
2021 Q3	$19.8M	Buy	413,573 +41,138	+11%	+$1.9M	0.03%	429
2021 Q2	$16.8M	Buy	372,435 +118,688	+47%	+$5.26M	0.02%	488
2021 Q1	$12.2M	Buy	253,747 +1,719	+0.7%	+$89.5K	0.02%	528
2020 Q4	$13.6M	Buy	252,028 +38,327	+18%	+$1.73M	0.02%	481
2020 Q3	$7.88M	Buy	213,701 +21	+0%	+$781	0.01%	533
2020 Q2	$6.62M	Sell	213,680 -8	-0%	-$222	0.01%	541
2020 Q1	$5.9M	Buy	+213,688	New	+$6.4M	0.01%	508

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eaton Vance Management's NEO Position: Q3 2022 in Review

Eaton Vance Management reduced its NeoGenomics (NEO) stake by 0.06% in Q3 2022, selling an estimated $2.56K and leaving 410,828 shares worth $3.54M. The position accounts for 0.01% of the portfolio, ranked #874.

Eaton Vance Management first reported a position in NEO in Q1 2020 and has held it in 11 quarters since. The position peaked at $19.8M in Q3 2021. 247 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

Eaton Vance Management held 410,828 shares of NeoGenomics worth $3.54M as of Q3 2022.
Eaton Vance Management sold 258 NeoGenomics shares in Q3 2022, an estimated $2.56K.
NeoGenomics made up 0.01% of Eaton Vance Management's portfolio in Q3 2022, its #874 holding.
Eaton Vance Management first reported a position in NeoGenomics in Q1 2020 and has held it in 11 quarters since.
Eaton Vance Management's NeoGenomics position peaked at $19.8M in Q3 2021.
247 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.